Rapid Micro Biosytems
Download the Whitepaper: Practical Applications for Automated Rapid Methods in Pharmaceutical Quality Control
Rapid Micro Biosytems
Quality control microbiology labs in pharmaceutical manufacturing are stretched to the limit. With increases in production lines, regulatory reporting demands and limited resources, the lab is looking for ways to become more efficient. Lean principles have started to take hold in the lab and waste is being stripped with new technologies and more efficient processes.
Over the last decade, forward-thinking microbiology QC labs have adopted a variety of rapid microbiological method (RMM) technologies, complementing – and in some cases, replacing – the century-old manual method of incubating and counting colonies for microbial testing. Automated, non-destructive, rapid methods offer several benefits to the QC lab, including the automation of error prone tasks, non-destructive results, a more streamlined validation process, integration to LIMS as well as rapid results. Through the creation of leaner, more efficient QC labs, these benefits have allowed several major pharmaceutical companies to increase their efficiency. Download your free copy to hear their stories!
Mark Severns
Email: info@rapidmicrobio.com
Web address: http://hubs.ly/y07BJn0
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
